RxDoctor Payments DataLook up a doctor →

Shiva Natarajan

Neurology · Germantown, TNNPI 1730132788

Payments from drug & device makers

$140,159in general payments, 2019–2025

Across 1,779 payments — averaging $78.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SK Life Science, Inc.$66K
  • Pfizer$22K
  • Biohaven Pharmaceuticals, Inc.$14K
  • Promius Pharma LLC$5K
  • Biohaven Pharmaceutical Holding Company Ltd.$5K
  • Novartis$3K
  • plus $24K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
SK Life Science, Inc.157$66,104
Pfizer117$22,429
Biohaven Pharmaceuticals, Inc.55$14,284
Promius Pharma LLC8$5,077
Biohaven Pharmaceutical Holding Company Ltd.38$5,076
Novartis197$2,824
AbbVie(2 entities)127$2,087
UCB, Inc.82$1,955
Livanova USA, Inc.21$1,938
Sunovion Pharmaceuticals Inc.56$1,925
AstraZeneca(2 entities)69$1,705
EMD Serono, Inc.80$961
Bristol Myers Squibb53$839
Argenx US, Inc.38$826
Acadia Pharmaceuticals Inc57$810
Teva Pharmaceuticals USA, Inc.56$745
Genentech USA, Inc.41$709
Amgen(2 entities)41$706
Biogen35$679
Lundbeck LLC31$633
Lilly USA, LLC37$587
Amneal Pharmaceuticals LLC47$545
Supernus Pharmaceuticals, Inc.54$515
Harmony Biosciences LLC16$515
Sanofi18$422
Jazz Pharmaceuticals Inc.20$413
Neurocrine Biosciences, Inc.18$381
Tanabe Pharma America, Inc.21$337
Sumitomo Pharma America, Inc.12$320
Banner Life Sciences, LLC18$279
TG Therapeutics, Inc.10$257
MDD US Operations, LLC16$230
E.r. Squibb & Sons, L.L.C.4$228
Johnson & Johnson(2 entities)6$194
Avanir Pharmaceuticals, Inc.11$170
Abbott2$167
Ipsen Biopharmaceuticals, Inc8$157
Boston Scientific3$149
Neurelis, Inc.8$146
Merz Pharmaceuticals, LLC4$135
CSL Behring7$119
Biosense Webster, Inc.1$102
Grifols USA, LLC5$98
Boehringer Ingelheim1$85
Aquestive Therapeutics, Inc.5$84
Corium, LLC6$82
Takeda Pharmaceuticals U.S.A., Inc.5$82
Kyowa Kirin, Inc.5$81
Bayer1$79
Eisai Inc.5$78
Alnylam Pharmaceuticals Inc.4$77
Vanda Pharmaceuticals Inc.4$75
Axsome Therapeutics, Inc.3$64
Nevro Corp.4$64
Adamas Pharmaceuticals, Inc.4$60
Acorda Therapeutics, Inc4$57
Otsuka America Pharmaceutical, Inc.3$51
Cycle Pharmaceuticals Inc2$45
Greenwich Biosciences, Inc.2$38
Piramal Critical Care2$38

How this compares

$140,159 in reported general payments places this provider in the 85th percentile of 361 neurology providers in Tennessee.

See all neurology providers in Tennessee →

Medicare billing

Part B allowed, 2024
$875,207
Medicare patients
1,260
Services billed
20,673

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Germantown

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →